Cargando…

Spontaneous Regression of Metastatic Lesions of Adenocarcinoma of the Gastro-Esophageal Junction

Spontaneous regression of cancer is a rarely recognized entity in modern medicine. Historically, this was recognized and hypothesized that an infection causes immune activation, indirectly stimulating the body to destroy tumor cells. Similarly, immune-oncology has now become a major modality in the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mitchell, Richard, Kaur, Amandeep, Munoh Kenne, Foma, Khan, Ahmed, Zafar, Wahib
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2021
Materias:	Internal Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590531/ https://www.ncbi.nlm.nih.gov/pubmed/34796071 http://dx.doi.org/10.7759/cureus.18784

Ejemplares similares

A Difficult and Rare Case of Warfarin Refractory Antiphospholipid Syndrome Presenting With Catastrophic Antiphospholipid Syndrome Complicated by Gastrointestinal Bleeding
por: Lim, William, et al.
Publicado: (2021)

Plasmapheresis Treatment of Hypertriglyceridemia-Induced Acute Pancreatitis: A Case Report
por: Munoh Kenne, Foma, et al.
Publicado: (2020)

Metastatic prostate cancer presenting as a posterior mediastinal mass: A rare presentation
por: Haider, Muhammad, et al.
Publicado: (2023)

A Novel Report on the Compassionate Use of Baricitinib in Treating a Pediatric Patient With Severe Symptoms of COVID-19 Infection
por: Atemnkeng, Francis, et al.
Publicado: (2021)

Successes and failures of angiogenesis blockade in gastric and gastro-esophageal junction adenocarcinoma
por: Salati, Massimiliano, et al.
Publicado: (2022)

Severe Malaria: A Case of a Significant Rapid Rise in the Parasite Level
por: Atere, Muhammed, et al.
Publicado: (2020)

Enduring complete metabolic response in metastatic adenocarcinoma of the gastro-oesophageal junction
por: Li, Minmin, et al.
Publicado: (2014)

Systemic chemotherapy for gastro-oesophagogastric junction adenocarcinoma and stomach adenocarcinoma in a metastatic setting
por: Sanjeevaiah, Aravind, et al.
Publicado: (2020)

Significance of tumour regression in lymph node metastases of gastric and gastro‐oesophageal junction adenocarcinomas
por: Reim, Daniel, et al.
Publicado: (2020)

Clinical role of ramucirumab alone or in combination with paclitaxel for gastric and gastro-esophageal junction adenocarcinoma
por: Davidson, Michael, et al.
Publicado: (2016)

Nutritional index for immune-checkpoint inhibitor in patients with metastatic gastro-esophageal junction/gastric cancer
por: Morelli, Cristina, et al.
Publicado: (2022)

Recent Advances in the Endoscopic Management of Gastro-esophageal Reflux Disorder: A Review of Literature
por: Ajmera, Kunal, et al.
Publicado: (2022)

Neoplastic and pre-neoplastic lesions of the oesophagus and gastro-oesophageal junction
por: Grillo, Federica, et al.
Publicado: (2020)

Evolving Management Strategies for Metastatic Esophageal and Gastroesophageal Junction Adenocarcinoma
por: Das, Satya, et al.
Publicado: (2018)

Epidermal Growth Factor (EGFR) copy number aberrations in esophageal and gastro-esophageal junctional carcinoma
por: Dahle-Smith, Åsa, et al.
Publicado: (2015)

Significance of Non-erosive Minimal Esophageal Lesions in Gastro-esophageal Reflux Disorder
por: Hong, Sung-Pyo, et al.
Publicado: (2004)

The Spontaneous Regression of Primary Gastrointestinal Malignancies: An Observational Review
por: Minacapelli, Carlos D, et al.
Publicado: (2022)

Phase II trial of modified FOLFOX6 and erlotinib in patients with metastatic or advanced adenocarcinoma of the oesophagus and gastro-oesophageal junction
por: Wainberg, Z A, et al.
Publicado: (2011)

Widespread choriocarcinoma metastases from de-differentiated gastro-esophageal junction primary adenocarcinoma: A case report with literature review
por: Schrader, Evan, et al.
Publicado: (2019)

Spontaneous Tumor Lysis Syndrome Secondary to Metastatic Small Cell Lung Cancer
por: Koura, Simran, et al.
Publicado: (2023)

The relevance of the Siewert classification in the era of multimodal therapy for adenocarcinoma of the gastro-oesophageal junction
por: Curtis, Nathan J, et al.
Publicado: (2014)

The Evolution of Neo-Adjuvant Therapy in the Treatment of Oesophageal and Gastro-Oesophageal Junction Adenocarcinomas
por: Dermanis, Alexander A., et al.
Publicado: (2023)

Robust Anti-tumor Response in a Patient with Metastatic Gastroesophageal Junction Adenocarcinoma on Long-term Maintenance Chemotherapy With Trastuzumab Alone: An Unusual Occurrence
por: Haider, Salman, et al.
Publicado: (2020)

Machine Learning for Future Subtyping of the Tumor Microenvironment of Gastro-Esophageal Adenocarcinomas
por: Klein, Sebastian, et al.
Publicado: (2021)

Minimum biopsy set for HER2 evaluation in gastric and gastro-esophageal junction cancer
por: Gullo, Irene, et al.
Publicado: (2015)

Clear Cell Hepatocellular Carcinoma with Spontaneous Regression of Primary and Metastatic Lesions
por: Jeon, Seong-Woo, et al.
Publicado: (2005)

Metastatic melanoma with spontaneous complete regression of a thick primary lesion
por: Khosravi, Hasan, et al.
Publicado: (2016)

S-1 plus cisplatin versus fluorouracil plus cisplatin in advanced gastric or gastro-esophageal junction adenocarcinoma patients: a pilot study
por: Li, Yuhong, et al.
Publicado: (2015)

Metastatic Lung Adenocarcinoma Presenting with Hypereosinophilia
por: Abughanimeh, Omar, et al.
Publicado: (2018)

Complexities of Long-Term Care With Gastro-Jejunal (GJ) Feeding Tubes and Enteral Migration During COVID-19 Pandemic Times: A Case Report
por: Zafar, Mansoor, et al.
Publicado: (2022)

Esophageal Adenocarcinoma in the Proximal Esophageal Segment: A Unique Presentation in a Male With Alcohol Abuse
por: Shiflett, Brandon S, et al.
Publicado: (2020)

Minimally invasive surgery for gastro-oesophageal junction adenocarcinoma: Current evidence and future perspectives
por: Bîrlă, Rodica, et al.
Publicado: (2023)

The Associations of Auto-Brewery Syndrome and Diabetes Mellitus: A Literature Review and Clinical Perspective
por: Patel, Priyansh, et al.
Publicado: (2023)

Serum HER 2 Extracellular Domain Level Is Correlated with Tissue HER 2 Status in Metastatic Gastric or Gastro-Oesophageal Junction Adenocarcinoma
por: Dai, Shu-Qin, et al.
Publicado: (2013)

Prognostic value of pre-therapeutic FDG-PET radiomic analysis in gastro-esophageal junction cancer
por: Amrane, Karim, et al.
Publicado: (2023)

Appropriateness of Using Patient-Derived Xenograft Models for Pharmacologic Evaluation of Novel Therapies for Esophageal/Gastro-Esophageal Junction Cancers
por: Dodbiba, Lorin, et al.
Publicado: (2015)

Gastro-Esophageal Reflux in Children
por: Rybak, Anna, et al.
Publicado: (2017)

Spontaneous regression of canine papillomavirus type 2-related papillomatosis on footpads in a dog
por: IYORI, Keita, et al.
Publicado: (2019)

Adjuvant concurrent chemoradiation using intensity-modulated radiotherapy and simultaneous integrated boost for resected high-risk adenocarcinoma of the distal esophagus and gastro-esophageal junction
por: Yaremko, Brian P, et al.
Publicado: (2013)

Phase II study of TP300 in patients with advanced gastric or gastro-oesophageal junction adenocarcinoma
por: Propper, David, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_l0kl9ijuk77n1vou260v1ioa4e